CALL OPTION AMENDMENT AGREEMENT dated as of April 6, 2020 Between LIGAND PHARMACEUTICALS INCORPORATED and GOLDMAN SACHS & CO. LLCCall Option Amendment Agreement • May 8th, 2020 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS CALL OPTION AMENDMENT AGREEMENT (this “Agreement”) with respect to the Call Option Confirmations (as defined below) is made as of April 6, 2020 between Ligand Pharmaceuticals Incorporated (“Company”) and Goldman Sachs & Co. LLC (“Dealer”).
CALL OPTION AMENDMENT AGREEMENT dated as of April 6, 2020 Between LIGAND PHARMACEUTICALS INCORPORATED and DEUTSCHE BANK AG, LONDON BRANCHCall Option Amendment Agreement • May 8th, 2020 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS CALL OPTION AMENDMENT AGREEMENT (this “Agreement”) with respect to the Call Option Confirmations (as defined below) is made as of April 6, 2020 between Ligand Pharmaceuticals Incorporated (“Company”) and Deutsche Bank AG, London Branch (“Dealer”).
CALL OPTION AMENDMENT AGREEMENT dated as of April 6, 2020 Between LIGAND PHARMACEUTICALS INCORPORATED and BARCLAYS BANK PLCCall Option Amendment Agreement • May 8th, 2020 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS CALL OPTION AMENDMENT AGREEMENT (this “Agreement”) with respect to the Call Option Confirmations (as defined below) is made as of April 6, 2020 between Ligand Pharmaceuticals Incorporated (“Company”) and Barclays Bank PLC (“Dealer”).
SECOND CALL OPTION AMENDMENT AGREEMENT dated as of January 28, 2021 Between LIGAND PHARMACEUTICALS INCORPORATED and DEUTSCHE BANK AG, LONDON BRANCHCall Option Amendment Agreement • February 24th, 2021 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS SECOND CALL OPTION AMENDMENT AGREEMENT (this “Agreement”) with respect to the Call Option Confirmations (as defined below) is made as of January 28, 2021 between Ligand Pharmaceuticals Incorporated (“Company”) and Deutsche Bank AG, London Branch (“Dealer”).
